HomeBusiness NewsPfizer slashes full-year earnings and revenue guidance as Covid treatment, vaccine sales... Business NewsFinance October 14, 2023 Pfizer slashes full-year earnings and revenue guidance as Covid treatment, vaccine sales slump By Jennifer Share FacebookTwitterPinterestWhatsApp - Advertisement - Pfizer said it anticipates sales of its Covid treatment Paxlovid and its vaccine will be $9 billion less than it had expected… Share FacebookTwitterPinterestWhatsApp Jenniferhttp://patriotstribune.org - Advertisement - Stay Connected 16,985FansLike4,568FollowersFollow Must Read Business News ‘Stop the price-gouging’: Biden hits corporations over high consumer costs Charles - November 28, 2023 Business News Wells Fargo unveils 2024 target, warns of ‘really, really sloppy’ first half for stocks November 28, 2023 Business News Shein files for U.S. IPO as fast-fashion giant looks to expand its global reach November 28, 2023 Business News Cramer says the market needs ‘some new heroes’ to create a sustainable rally November 28, 2023 Related News Business News ‘Stop the price-gouging’: Biden hits corporations over high consumer costs November 28, 2023 Business News Wells Fargo unveils 2024 target, warns of ‘really, really sloppy’ first half for stocks November 28, 2023 Business News Shein files for U.S. IPO as fast-fashion giant looks to expand its global reach November 28, 2023 Business News Cramer says the market needs ‘some new heroes’ to create a sustainable rally November 28, 2023 Business News Mounjaro is more effective than Ozempic for weight loss in overweight and obese adults, real-world study says November 28, 2023 LEAVE A REPLY Cancel reply Comment: Please enter your comment! Name:* Please enter your name here Email:* You have entered an incorrect email address! Please enter your email address here Website: Save my name, email, and website in this browser for the next time I comment.
